InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
67,185.50
(
0.70%
)
Post# of 650715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mc67

Send PM Follow Ignore
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

mc67

Re: None

Sunday, 08/09/2020 11:03:55 AM

Sunday, August 09, 2020 11:03:55 AM

Post# of 650715
$RLFTF Here it is. It stops replication of the virus and blocks cytokine storm, imo.

Quote:
aviptadil is shown as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes while also preventing synthesis of cytokines in the lung. It is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide, VIP), which has been granted FDA fast track designation, FDA emergency use IND authorisation, and an expanded access protocol.


https://www.thechronicleherald.ca/news/world/fda-lets-neurorx-relief-therapeutics-test-rlf-100-in-covid-19-patients-481945/

$RLFTF

"Dramatic Recovery Results"
WORLD WIDE COVERAGE https://health.economictimes.indiatimes.com/news/pharma/new-drug-rlf-100-shows-dramatic-recovery-in-covid-19-patients-suffering-respiratory-failure/77390990

DRAMATIC RECOVERY RESULTS !!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up